Cardlytics (CDLX) Projected to Announce Earnings on Wednesday

Cardlytics (NASDAQ:CDLXGet Free Report) is anticipated to release its Q2 2026 results after the market closes on Wednesday, August 5th. Analysts expect the company to announce earnings of ($2.30) per share and revenue of $37.0030 million for the quarter. Parties are encouraged to explore the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Wednesday, August 5, 2026 at 5:00 PM ET.

Cardlytics Stock Performance

CDLX stock opened at $3.74 on Monday. The company has a 50 day moving average price of $4.94 and a two-hundred day moving average price of $7.65. The stock has a market capitalization of $21.73 million, a P/E ratio of -0.21 and a beta of 0.62. Cardlytics has a one year low of $3.50 and a one year high of $32.80.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on CDLX. Lake Street Capital set a $10.00 price objective on Cardlytics in a research report on Friday, May 8th. Wall Street Zen downgraded Cardlytics from a “hold” rating to a “sell” rating in a research report on Saturday, June 13th. Weiss Ratings restated a “sell (e+)” rating on shares of Cardlytics in a report on Wednesday, July 8th. Finally, Needham & Company LLC restated a “hold” rating on shares of Cardlytics in a report on Thursday, June 18th. Two research analysts have rated the stock with a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Reduce” and an average price target of $10.00.

Read Our Latest Report on CDLX

Insiders Place Their Bets

In other news, CFO David Thomas Evans bought 5,000 shares of Cardlytics stock in a transaction that occurred on Monday, May 18th. The shares were purchased at an average price of $6.30 per share, for a total transaction of $31,500.00. Following the completion of the acquisition, the chief financial officer owned 31,793 shares of the company’s stock, valued at $200,295.90. The trade was a 18.66% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Amit Gupta sold 9,640 shares of the business’s stock in a transaction dated Monday, July 6th. The shares were sold at an average price of $4.39, for a total value of $42,319.60. Following the sale, the chief executive officer directly owned 113,850 shares of the company’s stock, valued at approximately $499,801.50. This trade represents a 7.81% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 18,289 shares of company stock valued at $80,289. Insiders own 5.90% of the company’s stock.

Institutional Trading of Cardlytics

Institutional investors and hedge funds have recently bought and sold shares of the business. Goldman Sachs Group Inc. lifted its position in Cardlytics by 15.1% during the fourth quarter. Goldman Sachs Group Inc. now owns 109,001 shares of the company’s stock valued at $125,000 after buying an additional 14,273 shares in the last quarter. Geode Capital Management LLC grew its stake in Cardlytics by 3.3% during the fourth quarter. Geode Capital Management LLC now owns 654,472 shares of the company’s stock worth $753,000 after buying an additional 20,908 shares during the period. Qube Research & Technologies Ltd acquired a new stake in shares of Cardlytics in the third quarter worth $55,000. Boothbay Fund Management LLC acquired a new stake in shares of Cardlytics in the third quarter worth $74,000. Finally, Virtu Financial LLC purchased a new position in shares of Cardlytics in the 4th quarter valued at $39,000. Institutional investors and hedge funds own 68.10% of the company’s stock.

Cardlytics Company Profile

(Get Free Report)

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.

See Also

Earnings History for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.